INVOKAMET XR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Canagliflozin; Metformin Hydrochloride.
| Product ID | 50458-942_2276e4f3-2afe-48ac-b293-fd4befeff063 | 
| NDC | 50458-942 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | INVOKAMET XR | 
| Generic Name | Canagliflozin And Metformin Hydrochloride | 
| Dosage Form | Tablet, Film Coated, Extended Release | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2016-09-20 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA205879 | 
| Labeler Name | Janssen Pharmaceuticals, Inc. | 
| Substance Name | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 
| Active Ingredient Strength | 150 mg/1; mg/1 | 
| Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2016-09-20 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA205879 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2016-09-20 | 
| Marketing Category | NDA | 
| Application Number | NDA205879 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2016-09-20 | 
| Marketing End Date | 2020-02-07 | 
| Ingredient | Strength | 
|---|---|
| CANAGLIFLOZIN | 150 mg/1 | 
| SPL SET ID: | 6868666b-c25e-40d1-9d1f-306bbe9390c1 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 50458-940 | INVOKAMET XR | canagliflozin and metformin hydrochloride | 
| 50458-941 | INVOKAMET XR | canagliflozin and metformin hydrochloride | 
| 50458-942 | INVOKAMET XR | canagliflozin and metformin hydrochloride | 
| 50458-943 | INVOKAMET XR | canagliflozin and metformin hydrochloride | 
| 50458-540 | INVOKAMET | canagliflozin and metformin hydrochloride | 
| 50458-541 | INVOKAMET | canagliflozin and metformin hydrochloride | 
| 50458-542 | INVOKAMET | canagliflozin and metformin hydrochloride | 
| 50458-543 | INVOKAMET | canagliflozin and metformin hydrochloride | 
| 63629-8260 | INVOKAMET | canagliflozin and metformin hydrochloride | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() INVOKAMET XR  86277042  5134045 Live/Registered  | 
        JOHNSON & JOHNSON  2014-05-09  |